Logo image of NTP

NAM TAI PROPERTY INC (NTP) Stock Fundamental Analysis

NYSE:NTP - New York Stock Exchange, Inc. - VGG639071023 - Common Stock - Currency: USD

4.215  -0.02 (-0.35%)

Premarket: 4.215 0 (0%)

Fundamental Rating

2

Taking everything into account, NTP scores 2 out of 10 in our fundamental rating. NTP was compared to 63 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of NTP have multiple concerns. While showing a medium growth rate, NTP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NTP had positive earnings in the past year.
NTP Yearly Net Income VS EBIT VS OCF VS FCFNTP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 50M -50M -100M

1.2 Ratios

Industry RankSector Rank
ROA 6.29%
ROE 17.86%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NTP Yearly ROA, ROE, ROICNTP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 2 -2 4 -4 6 -6

1.3 Margins

Industry RankSector Rank
OM 44.22%
PM (TTM) 31.71%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NTP Yearly Profit, Operating, Gross MarginsNTP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 -1K -2K -3K -4K

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, NTP has more shares outstanding
The debt/assets ratio for NTP has been reduced compared to a year ago.
NTP Yearly Shares OutstandingNTP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 10M 20M 30M
NTP Yearly Total Debt VS Total AssetsNTP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 200M 400M 600M

2.2 Solvency

NTP has an Altman-Z score of 0.76. This is a bad value and indicates that NTP is not financially healthy and even has some risk of bankruptcy.
NTP has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z 0.76
ROIC/WACCN/A
WACCN/A
NTP Yearly LT Debt VS Equity VS FCFNTP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 100M -100M 200M

2.3 Liquidity

NTP has a Current Ratio of 1.11. This is a normal value and indicates that NTP is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.11 indicates that NTP should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.11
NTP Yearly Current Assets VS Current LiabilitesNTP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 100M 200M 300M 400M

More info and screens

5

3. Growth

3.1 Past

NTP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 454.03%, which is quite impressive.
NTP shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 57.01% yearly.
NTP shows a strong growth in Revenue. In the last year, the Revenue has grown by 4398.24%.
The Revenue has been growing by 88.40% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)454.03%
EPS 3Y57.01%
EPS 5YN/A
EPS Q2Q%12.4%
Revenue 1Y (TTM)4398.24%
Revenue growth 3Y234.64%
Revenue growth 5Y88.4%
Sales Q2Q%426.36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NTP Yearly Revenue VS EstimatesNTP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 20M 40M 60M
NTP Yearly EPS VS EstimatesNTP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 3.40, the valuation of NTP can be described as very cheap.
NTP is valuated cheaply when we compare the Price/Earnings ratio to 29.62, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 3.4
Fwd PE N/A
NTP Price Earnings VS Forward Price EarningsNTP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.34
NTP Per share dataNTP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NTP!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

NAM TAI PROPERTY INC

NYSE:NTP (5/23/2022, 8:04:00 PM)

Premarket: 4.215 0 (0%)

4.215

-0.02 (-0.35%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)06-14 2022-06-14/bmo
Inst Owners14.95%
Inst Owner Change-99.38%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap165.22M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.4
Fwd PE N/A
P/S 1.08
P/FCF N/A
P/OCF N/A
P/B 0.61
P/tB N/A
EV/EBITDA 3.34
EPS(TTM)1.24
EY29.42%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.9
BVpS6.93
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.29%
ROE 17.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 44.22%
PM (TTM) 31.71%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 1.11
Altman-Z 0.76
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)454.03%
EPS 3Y57.01%
EPS 5YN/A
EPS Q2Q%12.4%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4398.24%
Revenue growth 3Y234.64%
Revenue growth 5Y88.4%
Sales Q2Q%426.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A